Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > GPS Healthcare Markets Analysis in Brazil
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

GPS Healthcare Markets Analysis in Brazil

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 01¿ù »óǰÄÚµå 59558
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This study provides a comprehensive overview of the pharmaceuticals and drugs market and the Healthcare IT market. Researched country is Brazil. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market shares by revenue and commercial forecasts from 2007-2011.

Table of Contents

1 MARKET INTRODUCTION AND EXECUTIVE SUMMARY

  • Market Introduction and Executive Summary
    • Executive Summary
    • Research Scope and Methodology
    • An Overview of the Healthcare Sector

2 HEALTHCARE IT

  • Market Measurements
    • Market Engineering Measurements
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Market Size and Forecast
    • Market Size and Forecast
  • Market Trends
    • Market Trends
    • Product Pricing Analysis
  • Competitive Structure and Market Share Analysis
    • Competitive Structure and Market Share Analysis

3 PHARMACEUTICALS AND DRUGS MARKET

  • Market Measurements
    • Market Enginnering Measurements
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Market Size and Forecast
    • Market Size and Forecasts
  • Market Trends
    • Market Trends
  • Competitive Structure and Market Share Analysis
    • Competitive Structure and Market Share Analysis
  • Product Measurements
    • Market Trends
    • Product Pricing Analysis

4 DECISION SUPPORT DATABASE

  • Decision Support Database
    • Total Healthcare Expenditure
    • Government Healthcare Expenditure
    • Private Healthcare Expenditure
    • Hospitals
    • Percent Pharma R&D Expenditure
    • Pharma R&D Expenditure
Back to Top